AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Barco NV

Earnings Release Feb 9, 2017

3911_er_2017-02-09_72f1ad5d-1370-4ed0-8da6-40b5aefb0da3.pdf

Earnings Release

Open in Viewer

Opens in native device viewer

FULL YEAR RESULTS: EBITDA margin expansion on high-single digit sales growth

Kortrijk, Belgium, 9 February 2017 – Today Barco (Euronext: BAR; Reuters: BARBt.BR; Bloomberg: BAR BB) announced results for the six and twelve month periods ended 31 December 2016.

Fiscal year 2016 financial highlights

  • Incoming orders at 1081.2 million euro (+ 3.6%)
  • Sales at 1102.3 million euro (+ 7.0%)
  • Gross profit margin at 34.4% (+ 1.6 ppts)
  • EBITDA of 88.0 million euro (+ 13.9 million euro) or 8.0% of sales (+ 0.8 ppts)
  • EBIT1 of 36.6 million euro (+34.9 million euro) or 3.3% of sales (+3.2 ppts)
  • Net income of 11.0 million euro
  • Free cash flow of 57.4 million euro
  • Net financial cash position of 286.6 million euro
  • Proposal to increase the dividend to 1.90 euro per share from 1.75 euro

Quote of the CEO, Jan De Witte

"Barco delivered solid sales growth and improved profitability for 2016. Initiatives to lower product costs and a favourable product mix led to a gain in gross profit margin versus 2015 and a year-over-year increase in EBITDA margin, even with significant investments in growth initiatives during the year," said Jan De Witte, CEO.

"Across our divisions, we advanced technology initiatives, expanded our channel network and increased sales of newer product lines. In Entertainment we continued to leverage our global leadership position in digital cinema, including strong results in China, while propelling sales of laser projectors globally in line with emerging demand for premium formats and technology upgrades. Notable in Healthcare, we saw a promising uptake of our network-enabled visualization solutions for the operating room and single-digit growth across the portfolio. In Enterprise strong momentum in ClickShare boosted the divisional profits while sales growth was offset by weaker sales in Control Rooms," added De Witte.

"For 2017, our goal is to continue generating sales and profitability growth through further leveraging our technology, software and services. We will continue to drive gross margin accretion initiatives and make choices across business activities, while continuing to invest in innovation," concluded De Witte.

Registered office: Pr. Kennedypark 35, B- 8500 Kortrijk, Belgium

1 This is EBIT before non-recurring charges and under the new capitalization methodology. Management considers EBIT (before non-recurring) to be a relevant performance measure in order to compare results over the period 2014 to 2016, as it excludes non-recurring items. Had Barco not changed its accounting treatment of product development costs, the EBIT margin for 2016 would have been approximately 5.4% compared to 5.0% in 2015 and 4.4% for 2014 (Calculated as EBIT before non-recurring and excluding amortizations less capitalized product development expenses for prior periods).

Outlook 2017

The following statements are forward looking and actual results may differ materially.

Assuming a stable economic environment and currencies at current levels, management expects further margin improvement on mid-single digit sales growth.

Dividend

The Board of Directors will propose to the General Assembly to increase the dividend from 1.75 euro to 1.90 euro per share to be paid out in 2017.

The following timetable will be proposed to the Annual General Shareholder meeting

  • Ex-date: Tuesday, 9 May 2017
  • Record date: Wednesday, 10 May 2017
  • Payment date: Thursday, 11 May 2017

Preliminary remarks

I. Barco's organizational structure

Barco is a global company developing solutions for entertainment, enterprise and healthcare markets.

  • Entertainment: The Entertainment division is the combination of the Cinema and Venues & Hospitality activities, which includes Professional AV, Events and the Retail & Advertising activities.
  • Enterprise: The Enterprise division is the combination of the Control Rooms activities and the Corporate activities. ClickShare is the main contributor to the Corporate activity which also includes the ventures Silex, X20 and Medialon.
  • Healthcare: The Healthcare division includes the activities in Diagnostic Imaging (Diagnostic and Modality Imaging) and in Surgical.

II. Items impacting 2016 profitability

The chart below displays the calculation of Barco's net income from EBITDA for FY16, FY15 and FY14 including various non-recurring items and a change in the accounting methodology for new product development costs and the variance for each line item between FY16 and FY 15.

(in millions of euro) FY16 FY15 FY14 Change
FY16-FY15
Comment
EBITDA before non-recurring 88.0 74.1 59.7 +13.9
Capitalized development 0 0 47.7 0 1.i
Amortizations of capitalized R&D (22.9) (49.4) (57.2) +26.6 1.ii
Depreciations & other
amortizations
(28.6) (22.9) (19.3) (5.7) 2.i
EBIT before non-recurring 36.6 1.7 30.9 +34.9
Impairment & Restructuring (12.9) (29.1) (3.4) +16.2 3.iⅈ
Interest & Taxes (5.1) 7.9 (5.9) (13.0) 4
Net Income from discontinued
operations
0.0 47.0 6.1 (47.0) 5.i
Gain on sale HQ (BE) 6.9 0 0 +6.9 5.ii
Non-controlling interest & share in
equity companies
(14.4) (10.1) (3.8) (4.3) 6
Net Income attributable to the equity
holder of the parent
11.0 17.5 23.9 (6.4)
    1. Change in accounting methodology for new product development costs
  • i. In light of shortened product life cycles and rapidly evolving technologies, Barco began expensing product development costs as incurred effective 1 January 2015. Previously the company had capitalized product development costs.
  • ii. The outstanding balance of capitalized development costs was amortized in 2015 and 2016.
    1. Depreciations and amortizations (excluding development)
  • i. Depreciation increased mainly due to the One Campus and OnePlatform investments.
  • ii. Amortizations increased due to the acquisitions of MTT and Medialon in the Entertainment and Enterprise division.

3. Impairment and restructuring charges

  • i. Barco recorded an impairment charge on goodwill of 7.1 million euro mainly related to investments in Patient Care solutions in its Healthcare division.
  • ii. The company also booked a restructuring charge of 5.8 million euro to reflect restructuring and redeployment measures implemented in its LED and lighting activity in the Entertainment division.

4. Effective tax rate

In 2015 and 2016 the equal effective tax rate was 20% but a shift from negative to positive taxable income in 2016 resulted in a negative 6.3 million euro in taxes.

5. Divestiture of Defense & Aerospace business on 31 January 2015

  • i. Net income from discontinued operations in 2015 of 47 million euro includes the gain on sale of the company's Defense and Aerospace business.
  • ii. As part of the divestiture, Barco's headquarters building was sold in 2016 resulting in a gain of 6.9 million euro.

6. Chinese Joint Venture

Non-controlling interest and share in equity companies amounted to 14.4 million euro in 2016 mainly driven by increased profit-contribution from its joint venture with the China Film group.

Part I - Consolidated results for the fiscal year 2016

Order Intake & Order Book

Order book at year end was 320.8 million euro, down 3.7% compared to a year earlier reflecting shorter delivery cycles in Entertainment and Enterprise and decreases in Healthcare following the booking of two material longer term bulk orders toward the end of 2015.

Order Book

(in millions of euro) FY16 FY15 FY14
Order book 320.8 333.2 302.2

Order intake was 1,081.2 million euro, an increase of 3.6% compared to last year driven by gains in Entertainment & Enterprise. By region declines in the Americas and a flat result in the EMEA region was offset by strong growth in the APAC region.

Order Intake

(in millions of euro) FY16 FY15 FY14
Order Intake 1,081.2 1,043.7 869.4

Order Intake by division

FY16 FY15 Change
Entertainment 574.8 536.4 +7.2%
Enterprise 290.2 287.0 +1.1%
Healthcare 216.3 221.2 -2.2%
Group 1,081.2 1,043.7 +3.6%

Order intake per region

FY16 FY15 Change
The Americas 34% 39% -11%
EMEA 32% 33% -1%
APAC 34% 28% +29%

Sales

Full year sales grew 7.0% led by strong gains in Entertainment and Healthcare. At constant currencies (excluding the impact mainly of the Chinese Yuan) sales growth would have been 8.6%.

All regions contributed to the growth, with strong gains in the APAC region.

Sales
(in millions of euro) FY16 FY15 FY14
Sales 1,102.3 1,028.9 908.4
Sales by division
FY16 FY15 Change
Entertainment 578.1 514.5 +12.4%
Enterprise 289.7 300.4 -3.6%
Healthcare 234.6 216.0 +8.6%
Group 1,102.3 1,028.9 +7.0%
Sales by region
FY16 FY15 Change
The Americas 36% 37% +3%
EMEA 31% 33% +4%
APAC 33% 30% +17%

Profitability

Gross profit

Gross profit increased from 337.8 to 378.8 million euro, an increase of 41.0 million euro. 2 Gross profit margin increased 1.6 percentage points to 34.4% compared to 32.8% in 2015, reflecting a positive product mix effect and the benefit of cost down engineering actions.

Operating expenses

Mainly as a result of planned investments in growth initiatives, total indirect cash expenses (excluding other operating results) increased to 322.7 million euro compared to 289.6 million euro a year earlier.

As a percentage of sales, indirect cash expenses were 29.3% compared to 28.1% for 2015.

  • On a cash basis, Research & Development expenses increased to 120.5 million euro from 100.8 million euro last year. As percentage of sales, cash R&D expenses were 10.9% compared to 9.8% a year earlier.

Including the amortization of outstanding capitalized development expenses of 22.9 million euro, reported R&D expenses amounted to 143.4 million euro or 13.0% of sales. See remarks on reporting methodology.

  • Sales & Marketing expenses increased to 147.1 million euro compared to 137.8 million euro in 2015. As a percent of sales, Sales & Marketing expenses were 13.3% of sales compared to 13.4% in 2015.
  • General & administration expenses were 55.1 million euro compared to 51.0 million euro last year and increased slightly as a percentage of sales from 4.9% to 5.0%. G&A expenses for the year included amortization of Barco's investment in the OnePlatform project. Barco began to amortize this investment beginning with the second semester of 2014.

Other operating results amounted to a positive 3.3 million euro compared to a positive 3.0 million euro last year, driven by a reversal in provisions for bad debt.

EBITDA & EBIT3

EBITDA grew 18.8% to 88.0 million euro compared to 74.1 million euro for the prior year. EBITDA margin was 8.0% versus 7.2% for 2015.

By division, EBITDA and EBITDA margin is as follows:

FY16 Sales EBITDA EBITDA %
Entertainment 578.1 30.4 5.3%
Enterprise 289.7 33.0 11.4%
Healthcare 234.6 24.6 10.5%
Group 1,102.3 88.0 8.0%

2 Gross profit and Sales and Marketing expenses are impacted by the reclassification of professional services overhead to cost of sales from sales & marketing expenses. The results for 2015 have been restated accordingly.

There is no impact on EBIT or net income resulting from this reclassification.

3 EBITDA and EBIT in this press release refer to "EBITDA and EBIT before non-recurring items" and exclude the 6.9 million euro gain on sale of building and other non recurring items such as impairment and restructuring costs and other non operating income: see Net Income.

FY16 FY15 Change
Entertainment 30.4 43.6 -30.1%
Enterprise 33.0 11.1 +197.7%
Healthcare 24.6 19.4 +26.6%
Group 88.0 74.1 +18.8%

EBITDA by division 2016 versus 2015 is as follows:

On group-level, Barco made good progress in expanding EBITDA which grew 18.8% driven by a turnaround performance in Enterprise and strong sales growth in Healthcare.

Significant EBITDA expansion in the Enterprise division was driven by both a strong contribution from the Corporate activity and a recovery of margins in the Control Rooms activity. The Healthcare division booked profitability gains based on sales growth and on the back of a favourable product mix. Planned investments in Entertainment caused an EBITDA decline.

EBIT was 30.5 million euro compared to a negative 27.4 million euro in 2015. Included in EBIT was a gain of 6.9 million euro on the sale of headquarter building, a charge of 5.8 million euro, primarily related to restructuring measures implemented in the Entertainment division's LED and Lighting activity, and impairment charges on goodwill and investments totalling 7.1 million euro related to Patient Care solutions in Healthcare.

EBIT before non-recurring charges was 36.6 million euro, or 3.3% of sales, compared to 1.7 million euro, or 0.2% of sales for 2015. In addition, 2016 EBIT before non-recurring included 22.9 million euro in amortization of the outstanding balance of capitalized development costs.

Income taxes

In 2016 taxes were 6.3 million euro for a tax rate of 20.0%. Taxes in 2015 were 4.9 million euro positive for an effective tax rate of 20.0% on the continuing business as a result of negative earnings before taxes.

Net income

Net income attributable to the equity holders was 11.0 million euro after deducting third party interests to the amount of 14.4 million euro mainly related to the Joint Venture with China Film Group.

Net income per ordinary share (EPS) was 0.91 euro compared to 1.45 euro in 2015. Fully diluted earnings per share were 0.88 euro compared to 1.41 euro.

Registered office: Pr. Kennedypark 35, B- 8500 Kortrijk, Belgium

Cash Flow & Balance Sheet

Free Cash Flow and Working Capital

Free cash flow for the year was 57.4 million euro compared to a 110.3 million euro for 2015 and 14.9 million euro for 2014.

(in millions of euro) FY16 FY15 FY14
Gross operating Cash Flow4 81.9 67.4 97.4
Changes in trade receivables 0.2 (5.4) (19.7)
Changes in inventory (2.8) 27.6 (11.9)
Changes in trade payables (2.7) 16.3 0.2
Other Changes in net working capital 11.9 32.8 4.7
Change in net working capital 6.6 71.2 (26.7)
Net operating Cash Flow 88.5 138.6 70.7
Interest Income/expense 4.1 0.2 (1.1)
Income Taxes (11.5) (14.9) (3.0)
Cash flow from operating activities 81.1 123.9 66.6
Expenditure on product development - - (47.7)
Purchase of tangible and intangible FA (excl.
One Campus)
(24.2) (14.7) (8.3)
Proceeds on disposal of tang and intang FA 0.6 1.1 4.3
Cash flow from investing (23.7) (13.6) (51.7)
FREE CASH FLOW 57.4 110.3 14.9

Driven in large part by cost down initiatives in the second semester of the year, Barco generated a higher gross operating cash flow of 81.9 million euro versus 67.4 million euro in 2015.

Net working capital was -5% of sales, a 3 percentage point improvement versus 2015.

Trade receivables decreased 0.2 million euro and trade payables decreased 2.7 million euro. Inventory increased 2.8 million euro.

  • Trade receivables were 188.6 million euro versus 186.8 million euro at 30 June 2016 and 186.9 million euro at 31 December 2015. DSO's stood at 55 days, compared to 61 days at the end of the first half and 58 days at 31 December 2015.
  • At 166.2 million euro, inventory was 2.8 million euro higher than at the end of 2015. Inventory turns improved to 3.6, compared to 2.9 turns at the end of the first half in 2016 and at the same level as at 31 December 2015.
  • Trade payables stood at 135.1 million euro compared to 123.0 million euro at 30 June 2016 and 139.5 million euro at 31 December 2015.

Cash flow from investing activities increased to 23.7 million euro, versus 13.6 million euro in 2015, due to purchases of fixed assets for Barco's new headquarter.

4 Gross Operating Cash Flow is now defined to include the restructuring pay-out. The Gross Operating Cash Flows for 2015 and 2014 have been restated to reflect the same definition.

Capital Expenditure

Capital expenditure was 33.4 million euro, including the One Campus investment of 9.1 million euro. For 2015 total capital expenditure was 43.0 million euro, including One Campus investments.

Return on Capital Employed

ROCE, excluding the impact of amortizations on capitalized product development costs, was 15%, a 4 percentage points improvement versus last year.

Capitalized Development

The outstanding balance of capitalized product development costs was amortized in 2015 and 2016. Outstanding capitalized development costs stood at 0 million euro at the end of year compared to 22.8 million euro at the end of 2015 and 71.4 million euro at 31 December 2014. Due to the Board's decision regarding Barco's capitalization methodology, since 1 January 2015, product development costs have been expensed as incurred.

Goodwill

Goodwill on the group level stood at 124.3 million euro compared to 132.4 million euro at the end of 2015 and 143.8 million euro at the end of 2014.

During 2016, Barco recorded impairment charges on goodwill and investments totalling 7.1 million euro mainly related to Healthcare division investments in the Patient Care activities acquired from Jaotech in 2012.

Cash position

Barco ended the year with a net financial cash position of 286.6 million euro compared to 265.1 million euro at the end of 2015.

The increase reflects higher free cash flow and proceeds from the sale of the headquarter building in Kortrijk partially offset by dividend payments and investments for the acquisition of MTT and Medialon and the One Campus project.

Immediately available net cash or net cash excluding the cash in the China Film Group joint venture amounted to 186.6 million euro, essentially flat with last year.

Part II - Consolidated results for 2H16

Financial highlights 2H16

  • Order intake for the semester was 548.3 million euro, from 521.2 million euro a year earlier (+5.2%).
  • Sales were 573.1 million euro from 522.7 million euro in 2H15 (+9.7%)
  • Gross profit margin was 32.9% versus 32.3% in 2H15.
  • EBITDA was 38.6 million euro versus 33.5 million euro in 2H15. EBITDA margin was 6.7% compared to 6.4% in 2H15.
  • EBIT5 was 12.4 million euro versus a negative 5.7 million euro in 2H15, reflecting the temporary impact of amortization of outstanding capitalized product development expenses.
  • Free cash flow for the second semester was 86.4 million euro compared to 95.8 million euro for the same period last year.

Order Intake & Order Book

Order intake was 548.3 million euro, an increase of 27.1 million euro or 5.2% compared to last year, driven by increases in the Entertainment and Enterprise divisions, partially offset by a decline in Healthcare.

The order book closed at 320.8 million euro at the end of the second semester of 2016.

Order Book

(in millions of euro) 2H16 1H16 2H15 1H15 2H14
Order book 320.8 332.4 333.2 333.1 302.2
Order Intake
(in millions of euro) 2H16 1H16 2H15 1H15 2H14
Order Intake 548.3 532.9 521.2 522.5 418.3
Order Intake by division
(in millions of euro) 2H16 2H15 Change
Entertainment 291.2 239.4 +21.6%
Enterprise 146.5 151.8 -3.5%
Healthcare 110.6 130.3 -15.2%
Group 548.3 521.2 +5.2%
Order intake per region
2H16 2H15 Change
The Americas 33% 41% -17%
EMEA 31% 34% -4%
APAC 36% 24% +56%

5 EBIT before non recurring charges

Page 11 of 1 Barco NV, Beneluxpark 21, B-8500 Kortrijk, Belgium Registered office: Pr. Kennedypark 35, B- 8500 Kortrijk, Belgium

Sales

Second semester sales continued to grow at the group level. Growth was driven by a strong push in both Healthcare and Entertainment. Sales in the Americas and EMEA region were essentially flat compared to last year while the APAC region was very robust.

Sales
(in millions of euro) 2H16 1H16 2H15 1H15 2H14
Sales 573.1 529.2 522.7 506.2 474.3
Sales by division
(in millions of euro) 2H16 2H15 Change
Entertainment 305.4 250.1 +22.2%
Enterprise 148.8 161.5 -7.9%
Healthcare 118.9 111.3 +6.9%
Group 573.1 522.7 +9.7%
Sales by region 2H16 2H15 Change
The Americas 34% 38% -1%
EMEA 31% 34% +1%

APAC 35% 28% +35%

Profitability

Gross profit

Gross profit was 188.8 million euro for the second semester of 2016, a robust increase of 11.7% compared to 169.1 million euro for the second semester 2015.6

Gross profit margin increased by 0.6 percentage points to 32.9% for the second half of 2016 compared to 32.3% for the second half of 2015.

Indirect expenses

Total operational cash expenses, excluding other operating results were 168.5 or 29.4% of sales compared to 152.6 million euro or 29.2% of sales for the second half of 2015. New product launches and investments in growth initiatives drove the increases in Research and Development and in Sales and Marketing expenses.

  • On a cash basis, Research & Development expenses increased to 64.4 million euro from 53.7 million euro last year. As a percent of sales, cash R&D expenses amounted to 11.2% of sales compared to 10.3% a year earlier. Including the amortization of outstanding capitalized development expenses of 10.0 million euro, reported R&D expenses amounted to 74.4 million euro or 13.0 % of sales. For the second half of 2015 reported R&D expenses were 79.9 million euro or 15.3% of sales, including the amortization of outstanding capitalized development expenses of 26.2 million euro.
  • Sales & Marketing expenses increased to 75.0 million euro compared to 71.3 million euro for the second half of 2015. 7 As a percent of sales, Sales & Marketing expenses were 13.1% in 2H16 compared to 13.6% in 2H15.
  • General & administration expenses were 29.0 million euro, or 5.1% of sales compared to 27.6 million euro or 5.3% of sales last year.
  • Other operating results amounted to a positive 2.0 million euro compared to a positive 3.9 million euro last year.

6 Gross profit and Sales and Marketing expenses are impacted by the reclassification of professional services overhead to cost of sales from sales & marketing expenses. The results for 2015 have been restated accordingly.

7 See footnote 3

There is no impact on EBIT or net income resulting from this reclassification. (More information in the Annual Report 2016)

EBITDA & EBIT8

EBITDA was 38.6 million euro, compared to 33.5 million euro for the prior year second semester.

EBITDA margin was 6.7% versus 6.4% for the second half of 2015, with strong contributions from the Enterprise and Healthcare division partially offset by a slower performance in the Entertainment division due to heavy investments in growth initiatives.

By division, EBITDA and EBITDA margin was as follows:

2H16 (in millions of euro) Sales EBITDA EBITDA %
Entertainment 305.4 7.7 2.5%
Enterprise 148.8 17.4 11.7%
Healthcare 118.9 13.5 11.4%
Group 573.1 38.6 6.7%

EBITDA by division 2H16 versus 2H15 is as follows:

(in millions of euro) 2H16 2H15 Change
Entertainment 7.7 16.1 -52.2%
Enterprise 17.4 9.6 +81.3%
Healthcare 13.5 9.1 +48.4%
Group 38.6 33.5 +15.2%

EBIT before non-recurring was 12.4 million euro or 2.2% of sales and included 10.0 million euro of amortizations of capitalization of product development expenses. For the second half of last year EBIT was 5.8 million euro negative.

Net income

Net income attributable to the equity holders for 2H16 was a negative 7.1 million euro, and is net after restructuring and impairments charges of 12.9 million euro and the third party interests of 7.9 million euro mainly related to the Joint Venture with China Film Group.

8 EBITDA and EBIT in this press release refer to "EBITDA and EBIT before non-recurring items" and exclude the 6.9 million euro gain on sale of building and other non recurring items such as impairment and restructuring costs and other non operating income.

Part III – Divisional results for fiscal year 2016

(in millions of euro) FY16 FY15 FY14 Change vs
FY159
Orders 574.8 536.4 431.2 +7.2%
Sales 578.1 514.5 459.7 +12.4%
EBITDA 30.4 43.6 34.3 -30.1%
EBITDA margin 5.3% 8.5% 7.5%

ENTERTAINMENT DIVISION

The Entertainment division delivered another excellent year with robust gains in the Cinema business, particularly in China.

EBITDA and EBITDA margin declined year-over-year reflecting sizeable investments in new product development and new product launches, notably Barco Escape and flexible LEDsolutions.

In the Cinema segment, sales growth was driven by strong demand for new projectors in emerging regions and particularly in China; in more mature geographies sales growth was driven by rising demand from existing and new customers for technology upgrades and premium format solutions. In addition the segment increased the number of flagship laser projector installations worldwide and enjoyed strong demand for its laser phosphor projectors, launched in 3Q16.

Leveraging its large installed base, the segment continued to increase service and maintenance revenue.

Barco tested and proved the appeal of Barco Escape which was installed in almost 40 theatres worldwide in support of the summer release of Star Trek. Audience feedback was positive, customers reported higher box-office receipts and the company is now exploring different options to secure content financing for the Escape format.

The Lobby initiative continued to gain traction in the North American market. As mentioned in the first-half report, Barco acquired MTT Innovation Inc. in June 2016, an investment which adds to its expertise in next-generation projection technology.

The Venues and Hospitality segment's performance was mixed with good uptake in the fixed install market offset by slower order flow and increased competition in the events activity. Orders for fixed installs were strong reflecting inroads made with museums, theme parks and arenas. New laser phosphor solutions and advanced flexible LED solutions were launched, expanding the segment's product portfolio and strengthening its competitive positioning.

Registered office: Pr. Kennedypark 35, B- 8500 Kortrijk, Belgium

9 As of 2016, the remaining projector activity which had been part of Enterprise was transferred to the Entertainment division. Barco has not presented restated historical data. The sales results of the projector activity are not material to an analysis of the performance trends of the Entertainment and Enterprise divisions. (More information in the Annual Report 2016, Segment Information)

ENTERPRISE DIVISION

(in millions of euro) FY16 FY15 FY14 Change vs
FY1510
Orders 290.2 287.0 255.5 +1.1%
Sales 289.7 300.4 259.8 -3.6%
EBITDA 33.0 11.1 8.7 +197.7%
EBITDA margin 11.4% 3.7% 3.3%

The Enterprise Division delivered a three-fold increase in EBITDA and 770 basis point gain in EBITDA margin even though sales declined slightly on weak demand and project delays in Control Rooms. The Corporate segment accounted for half of Enterprise's sales.

In the Corporate segment, product portfolio and partner channel expansions drove sales growth and sustained momentum for ClickShare, which has now been equipped in 200,000 meeting rooms, up from 100,000 for 2015. Although Barco made considerable progress in extending ClickShare's footprint in the US and EMEA regions, substantial opportunities for broader and deeper market coverage in all regions remain.

Control Rooms posted an increase in sales of software that was overshadowed by a decline in hardware sales, driven by a slower Oil and Gas market, intensified competition from LCDs and delayed projects and product releases. Investments made in software and workflow solutions, new hardware releases and a joint venture in China position the segment to strengthen its competitive position in 2017. While investing in this transition, steps taken in 2015 to improve operating expense efficiency helped Control Rooms move closer to restoring profitability. The Enterprise division also closed the acquisition of Medialon in Q2 of 2016, adding complementary capabilities in control solutions and offering networked solutions for the Corporate and Education markets.

10 As of 2016, the remaining projector activity which had been part of Enterprise was transferred to the Entertainment division. Barco has not presented restated historical data. The sales-results of the projector activity are not material to an analysis of the performance trends of the Entertainment and Enterprise divisions. (More information in the Annual Report 2016, Segment Information)

(in millions of euro) FY16 FY15 FY14 Change vs
FY15
Orders 216.3 221.2 181.0 -2.2%
Sales 234.6 216.0 186.7 +8.6%
EBITDA 24.6 19.4 10.3 +26.6%
EBITDA margin 10.5% 9.0% 5.5%

HEALTHCARE DIVISION

Healthcare achieved a 10.5% EBITDA margin for 2016 reflecting an 8.6% increase in sales and strict control over operating expenses. Although orders were slightly below 2015 which benefited from some bulk orders, the division's order book remains healthy. Excluding the 2015 bulk orders, order intake grew 9%.

The Healthcare division strengthened its market leadership in the diagnostic market with a steady performance while modality experienced softer demand. Surgical sustained strong momentum worldwide and successfully entered the North America market.

The division completed the integration of Advan, launched a 4K surgical display and also decided to scale back its patient care activities and to support the momentum in its surgical activities.

The division increased its sales in China driven by continued efforts in business development and by expanding local capabilities in this high-growth developing market.

Conference call

Barco will host a conference call with investors and analysts on 9 February 2017 at 9:00 a.m. CET (3:00 am EST), to discuss the results of 2016. Jan De Witte, CEO, Ann Desender, CFO and Carl Vanden Bussche, IRO, will host the call. An audio cast of this conference call will be available on the Company's website www.barco.com by 12:30 p.m. Brussels time (6:30 a.m. EST).

Additional information

Auditor's report

The statutory auditor, Ernst & Young Bedrijfsrevisoren/Réviseurs d'Entreprises represented by Marnix Van Dooren has confirmed that the audit procedures, which have been substantially completed, have not revealed any material adjustments which would have to be made to the accounting information included in this press release.

The complete audit report related to the audit of the consolidated financial statements will be shown in the 2016 annual report that will be published on the Internet (www.barco.com).

Financial Calendar 2017

- Capital Markets Day Thursday 16 March 2017
- Trading update 1Q17 Friday 21 April 2017
- Annual general shareholders meeting Thursday 27 April 2017
- Announcement of results 1H17 Wednesday 19 July 2017
- Trading update 3Q17 Wednesday 18 October 2017

About Barco

Barco, a global technology company, designs and develops networked visualization products for the Entertainment, Enterprise and Healthcare markets. Barco has its own facilities for Sales & Marketing, Customer Support, R&D and Manufacturing in Europe, North America and APAC. Barco (NYSE Euronext Brussels: BAR) is active in more than 90 countries with 3,500 employees worldwide. Barco posted sales of 1.102 billion euro in 2016.

For more information and the Annual report 2016, please visit the Company's website at www.barco.com

© Copyright 2017 by Barco

For more information, please contact:

Carl Vanden Bussche, VP Investor Relations +32 56 26 23 22 or [email protected]

Registered office: Pr. Kennedypark 35, B- 8500 Kortrijk, Belgium

ANNEX I

FINANCIAL TABLES

Income Statement 2016 2015 2014
(in thousands of euro)
Net sales 1,102,342 1,028,856 908,368
Cost of goods sold -723,538 -691,091 -622,090
Gross profit 378,804 337,765 286,278
Research and development expenses -143,362 -150,222 -99,689
Sales and marketing expenses -147,088 -137,829 -116,679
General and administration expenses -55,122 -50,977 -44,334
Other operating income (expense) - net 3,325 2,960 5,306
EBIT (before non-recurring) 36,557 1,698 30,882
Restructuring and goodwill impairment -12,939 -29,099 -3,373
Gain on sale building 6,866 - -
Other non-operating income/(expense) 33 35 -
EBIT 30,516 -27,366 27,509
Interest income 4,401 7,103 3,022
Interest expense -3,161 -4,098 -4,156
Income/(loss) before taxes 31,756 -24,360 26,375
Income taxes -6,345 4,879 -4,748
Result after taxes 25,411 -19,481 21,628
Share in the result of joint ventures and associates 263 -1,073 68
Net income/(loss) from continuing operations 25,674 -20,554 21,696
Net income from discontinued operations - 47,031 6,094
Net income 25,674 26,477 27,790
Net income attributable to non-controlling interest 14,652 9,009 3,856
Net income attributable to the equity holder of the
parent
Net income/(loss) (continuing) attributable to the
11,023 17,468 23,933
equity holder of the parent
Net income (discontinued) attributable to the equity
11,023 -29,563 17,840
holder of the parent - 47,031 6,094
Earnings per share (in euro) 0.91 1.45 1.96
Diluted earnings per share (in euro) 0.88 1.41 1.92
Earnings (continuing) per share (in euro) 0.91 -2.45 1.46
Diluted earnings (continuing) per share (in euro) 0.88 -2.38 1.43
Selected Financial Ratios 2016 2015 2014
EBITDA (before non-recurring) 88,002 74,080 59,695
EBITDA on sales (before non-recurring) 8.0% 7.2% 6.6%
EBIT on sales (before non-recurring) 3.3% 0.2% 3.4%
EBIT on sales 2.8% -2.7% 3.0%
Total debt to equity 13.6% 15.3% 14.3%
Balance sheet 31 Dec 2016 31 Dec 2015 31 Dec 2014
(in thousands of euro)
ASSETS
Goodwill 124,255 132,386 143,774
Capitalized development cost 0 22,846 71,351
Other intangible assets 75,765 52,628 55,926
Land and buildings 53,019 20,221 21,315
Other tangible assets 50,916 72,346 44,597
Investments 14,460 9,031 14,360
Deferred tax assets 89,100 78,031 68,219
Other non-current assets 19,112 23,226 15,736
Non-current assets 426,627 410,715 435,278
Inventory 166,202 165,960 185,631
Trade debtors 188,561 186,910 170,486
Other amounts receivable 15,584 26,157 18,940
Cash and cash equivalents 353,549 341,277 145,340
Prepaid expenses and accrued income 8,709 9,308 8,948
Assets from discontinued operations 0 0 110,761
Current assets 732,605 729,612 640,106
Total Assets 1,159,231 1,140,327 1,075,384
EQUITY AND LIABILITIES
Equity attributable to equityholders of the parent 590,243 597,739 587,415
Non-controlling interest 25,244 13,925 7,146
Equity 615,487 611,664 594,561
Long-term debts 66,811 79,527 57,737
Deferred tax liabilities 8,813 4,462 6,830
Other long-term liabilities 11,198 2,839 0
Non-current liabilities 86,823 86,828 64,567
Current portion of long-term debts 11,500 10,000 7,130
Short-term debts 2,085 2,124 19,253
Trade payables 135,127 139,504 109,091
Advances received on customers 109,064 113,874 107,544
Tax payables 13,880 13,016 15,171
Employee benefit liabilities 57,050 48,757 44,759
Other current liabilities 9,684 7,690 5,204
Accrued charges and deferred income 58,050 59,967 33,390
Provisions 60,481 46,903 40,148
Liabilities from discontinued operations 0 0 34,567
Current liabilities
Total Equity and Liabilities
456,922
1,159,231
441,835
1,140,327
416,257
1,075,385
Cash flow statement 2016 2015 2014
(in thousands of euro)
Cash flow from operating activities
EBIT before non-recurring 36,557 1,698 30,882
Impairment of capitalized development costs 1,364 4,866 7,244
Restructuring -4,917 -3,622 -3,340
Gain on sale Orthogon -1,000 -1,406 -6,650
Amortization capitalized development cost 21,509 44,575 49,969
Depreciation of tangible and intangible fixed assets 28,572 22,906 19,291
Gain/(Loss) on tangible fixed assets -401 -543 -69
Share options recognized as cost 1,234 1,313 1,268
Share in the profit/(loss) of joint ventures and associates 263 -1,073 68
Discontinued operations: cash flow from operating activities 0 -4,407 21,281
Gross operating cash flow 83,180 64,308 119,944
Changes in trade receivables 205 -5,443 -19,669
Changes in inventory -2,829 27,565 -11,915
Changes in trade payables -2,676 16,297 220
Other changes in net working capital 11,883 32,773 4,708
Discontinued operations: change in net working capital 0 12,767 538
Change in net working capital 6,583 83,958 -26,119
Net operating cash flow 89,763 148,266 93,825
Interest received 7,272 4,303 3,022
Interest paid -3,161 -4,098 -4,156
Income taxes -11,538 -14,938 -2,993
Discontinued operations: income taxes and interest
received/(paid) 0 -5,094 -17
Cash flow from operating activities 82,337 128,439 89,681
Cash flow from investing activities
Expenditure on product development 0 0 -47,691
Purchases of tangible and intangible fixed assets -24,241 -14,730 -8,326
Proceeds on disposals of tangible and intangible fixed assets 578 1,137 4,312
Proceeds from sale of building 9,292 0 0
Acquisition of Group companies, net of acquired cash -10,229 -9,635 -21,915
Disposal of group companies, net of disposed cash 1,000 139,622 10,590
Other investing activities -16,667 -23,072 -15,699
Discontinued operations: cash flow from investing activities
Cash flow from investing activities (including
0 -887 -12,888
acquisitions and divestments) -40,267 92,435 -91,616

Page 21 of 1 Barco NV, Beneluxpark 21, B-8500 Kortrijk, Belgium Registered office: Pr. Kennedypark 35, B- 8500 Kortrijk, Belgium

2016 2015 2014
Cash flow from financing activities
Dividends paid -20,951 -19,364 -18,410
Dividends received 376 0 0
Capital increase/(decrease) 2,498 895 314
(Acquisition)/sale of own shares 5,684 -1,744 -11,335
Proceeds from (+), payments (-) of long-term liabilities -11,381 8,740 19,346
Proceeds from (+), payments (-) of short-term liabilities -2,239 -17,980 -8,255
Dividend distributed to non-controlling interest -5,707 -3,006 -1,792
Capital increase from non-controlling interest 2,912 406 0
Discontinued operations: cash flow from financing activities 0 0 -36
Cash flow from financing activities -28,809 -32,053 -20,169
Net increase/(decrease) in cash and cash equivalents 13,261 188,821 -22,103
Cash and cash equivalents at beginning of period 341,277 145,340 156,545
Cash and cash equivalents (CTA) -989 7,116 10,897
Cash and cash equivalents at end of period 353,549 341,277 145,340
Results per division 2016 2015 2014
(in thousands of euro)
Sales
Entertainment 578,057 513,332 459,241
Healthcare 234,633 215,896 186,478
Enterprise 289,652 299,627 258,082
Ventures 0 0 4,567
Group 1,102,342 1,028,856 908,368
EBITDA (before non-recurring)
Entertainment 30,446 43,561 34,250
Healthcare 24,572 19,403 10,300
Enterprise 32,984 11,081 8,678
Ventures 0 6,467
Group 88,002 74,045 59,695

ANNEX II

TRADING UPDATE 4Q16

Trading update fourth quarter 2016

Order Book
(in millions of euro) 4Q16 3Q16 2Q16 1Q16 4Q15 3Q15
Order book 320.8 330.1 332.4 350.5 333.2 367.2
Order Intake
(in millions of euro) 4Q16 3Q16 2Q16 1Q16 4Q15 3Q15
Order Intake 281.7 266.7 252.0 280.8 251.9 269.3
Sales
(in millions of euro) 4Q16 3Q16 2Q16 1Q16 4Q15 3Q15
Sales 311.3 261.8 274.1 255.1 292.4 230.3
Sales
(in millions of euro) 4Q16 4Q15 Change
Entertainment 163.4 140.3 +16.5%
Enterprise 84.2 94.7
-11.1%
Healthcare 63.8 57.8
+10.3%
Intra-group eliminations -0.0 (0.4)
Group 311.3 292.4 +6.5%

Talk to a Data Expert

Have a question? We'll get back to you promptly.